These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8517511)

  • 1. Delayed onset of alcuronium effect in children with cyanotic congenital heart disease.
    Keneally JP; Goonetilleke PH; Ramzan IM
    Anaesth Intensive Care; 1993 Apr; 21(2):197-200. PubMed ID: 8517511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of alcuronium in children with acyanotic and cyanotic cardiac disease undergoing cardiopulmonary bypass surgery.
    Weekes LM; Keneally JP; Goonetilleke PH; Ramzan IM
    Paediatr Anaesth; 1995; 5(6):369-74. PubMed ID: 8597969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative neuromuscular block following atracurium or alcuronium in children.
    Meretoja OA; Gebert R
    Can J Anaesth; 1990 Oct; 37(7):743-6. PubMed ID: 2171792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response of alcuronium and d-tubocurarine in infants, children and adolescents.
    Meretoja OA; Brown TC; Clare D
    Anaesth Intensive Care; 1990 Nov; 18(4):449-51. PubMed ID: 2268007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The onset of alcuronium and tubocurarine: alone and in combination.
    Roberts SP; Pollard BJ
    Acta Anaesthesiol Scand; 1993 Feb; 37(2):195-8. PubMed ID: 8383403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacodynamics of alcuronium in the elderly.
    Kent AP; Hunter JM
    Anaesthesia; 1991 Apr; 46(4):271-4. PubMed ID: 2024743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response curves for alcuronium and pancuronium alone and in combination.
    Shanks CA
    Anaesth Intensive Care; 1982 Aug; 10(3):248-51. PubMed ID: 7125191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between vascular endothelial growth factor and leptin in children with cyanotic congenital heart disease.
    Aydin HI; Yozgat Y; Demirkaya E; Olgun A; Okutan V; Lenk MK; Ozcan O
    Turk J Pediatr; 2007; 49(4):360-4. PubMed ID: 18246735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical research of muscular relaxation induced by alcuronium and pancuronium].
    Gong Z; Ye T; Pei L; Luo X; Luo A
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Aug; 17(4):301-4. PubMed ID: 8575054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The dose-response relationship and time course of the neuromuscular blockade by alcuronium].
    Pühringer F; Adler R; Mitterschiffthaler G; Koller J; Mair P; Khünl-Brady KS; Agoston S
    Anaesthesist; 1990 Oct; 39(10):508-12. PubMed ID: 1980578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic changes in children with cyanotic and acyanotic congenital heart disease.
    Goel M; Shome DK; Singh ZN; Bhattacharjee J; Khalil A
    Indian Heart J; 2000; 52(5):559-63. PubMed ID: 11256779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atracurium--increased duration of its effect following alcuronium].
    Janda A; Mühlsteiger B; Schwarz S
    Anasth Intensivther Notfallmed; 1990 Jun; 25(3):203-5. PubMed ID: 2393076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oxidative state of children with cyanotic and acyanotic congenital heart disease.
    Ercan S; Cakmak A; Kösecik M; Erel O
    Anadolu Kardiyol Derg; 2009 Dec; 9(6):486-90. PubMed ID: 19965321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
    Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does suxamethonium influence the subsequent dose requirements of alcuronium and its reversibility in children?
    Brown TC; Meretoja OA; Clare D; Bell B
    Anaesth Intensive Care; 1990 Nov; 18(4):479-82. PubMed ID: 2268013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma leptin levels in children with cyanotic and acyanotic congenital heart disease and correlations with growth parameters.
    Hallioglu O; Alehan D; Kandemir N
    Int J Cardiol; 2003 Nov; 92(1):93-7. PubMed ID: 14602223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming and the onset of neuromuscular blockade with alcuronium.
    Black AM; Hutton P; el-Hassan KM; Morgan G; Clutton-Brock TH
    Br J Anaesth; 1986 Aug; 58(8):827-33. PubMed ID: 3730230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance requirement of alcuronium in paediatric patients.
    Meretoja OA; Brown TC
    Anaesth Intensive Care; 1990 Nov; 18(4):452-4. PubMed ID: 2268008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sevoflurane anesthesia and cardiopulmonary bypass on renal function in cyanotic and acyanotic children undergoing cardiac surgery.
    Oc B; Akinci SB; Kanbak M; Satana E; Celebioglu B; Aypar U
    Ren Fail; 2012; 34(2):135-41. PubMed ID: 22150502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to nondepolarizing muscle relaxants in children with tumours.
    Brown TC; Gregory M; Bell B; Clare D
    Anaesth Intensive Care; 1990 Nov; 18(4):460-5. PubMed ID: 2176439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.